Elektrofi appoints Paul Herbert as SVP of Pharmaceutical Development
11 November 2020 -

Boston-based biotechnology company Elektrofi revealed on Wednesday that it has appointed Paul Herbert to the role of senior vice president of Pharmaceutical Development.

The company said Herbert is a highly experienced senior executive with a proven track record of about 30 years in the pharmaceutical industry.

Herbert is a an expert in product development and manufacturing for particle-based products and has led the development of twelve processes to NDA submission.

Before joining Elektrofi, Herbert served as vice president of Process Development & Engineering at Alkermes, where he led teams of up to 100 individuals in all aspects of drug product operations, including sterile process design, regulatory documentation, CDMO/CMO management, and clinical manufacturing.

Elektrofi is focused on improving administration for a range of medicines, such as monoclonal antibodies, therapeutic proteins and other large molecule drugs. The company's breakthrough formulation platform is designed to enable stabilized, highly concentrated formulations for subcutaneous administration.